IMA asks doctors not to advertise ‘guaranteed treatment’

  • News
  • April 30, 2016

New Delhi

The Indian Medical Association (IMA) has issued a circular to all its 2.5 lakh members warning them not to advertise “No Cure No Payment” or “guaranteed cure” stating both are violations of Medical Council of India (MCI) Code of Ethics Regulations as well as Drugs and Magic Remedies Act. The circular comes in the wake of the ongoing case against a doctor couple running an IVF clinic in Mumbai’s Colaba whose licenses were suspended by the Maharashtra Medical Council (MMC) for three months following complaints that they were promised of guaranteed pregnancy on their clinic website and even offered refund if the treatment failed. The Advertising Standards Council of India had filed a complaint against the doctor couple with MMC in 2014. A division bench of justices S C Dharmadhikari and G S Kulkarni of the Bombay High Court has refused to grant interim relief to the doctor couple. “Soliciting patients directly or indirectly by medical professionals is not permitted under the MCI rules and regulations. A doctor cannot also guarantee the results of their treatment,” said Dr K K Aggarwal, Secretary General of IMA. The IMA has also launched an awareness programme to educate its 2.5 lakh doctors across the country on ethical practices. Given its serious implications, we have been constantly making an effort to educate all our members on what is allowed and what is not allowed and ways to safeguard oneself and ensure delivery of a transparent service. There is also an urgent need to educate patients about how the success of all treatments cannot be guaranteed. They must understand that doctors are committed to saving lives and helping solve health issues. They, however, are humans and guaranteeing results is not possible.

  • Related Posts

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

    • News
    • May 27, 2025
    • 268 views
    Ramping Up Community for JeevanRaksha during Disasters

    CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

    India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

    Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

    Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

    Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

    Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

    Novartis wins approval for first malaria drug for newborns and babies

    Novartis wins approval for first malaria drug for newborns and babies